Par Drugs And Chemicals Limited is a publicly traded security listed on the NSE exchange.
Price & Volume Chart
Trading Range & Multiples
52-week channel & valuation snapshot.
Interactive Win/Loss Odds & Target Move Simulator (1W to 5Y)
1,236 Trading Days TestedSelect any holding horizon (1W, 1M, 3M, 6M, 1Y, 3Y, 5Y) and set your own custom ±% target move to test exact historical probabilities for PAR.
Radar Score
Quality · Valuation · Momentum · OwnershipA 0–100 factor score for Par Drugs And Chemicals Limited, recalculated after every market close.
PAR has a mixed factor profile — strengths in some pillars are offset by weaker readings in others.
A descriptive, rules-based summary of reported data — not a buy, sell or hold recommendation. How it's calculated
Quality & Capital Return
Weight: 30%- Subdued ROE of 11.8%
Valuation & Multiples
Weight: 25%- Trading at attractive 25%+ discount to sector P/E (10.8x vs 31.5x)
- Low book multiple (P/B 1.27x)
Technical Momentum & DMA
Weight: 25%- Maintaining position above 200-DMA institutional floor
- Overheated short-term RSI (45)
Institutional Conviction & Insiders
Weight: 20%Stock Snapshot & Key Numbers — Par Drugs And Chemicals Limited
NSE CloseClosing price, 52-week range, valuation multiples, and market capitalization.
Par Drugs And Chemicals Limited (PAR) is a Indian equity security listed on the NSE with ISIN INEPAR01010. As of the last recorded market session on Close on 06 Nov 2026, the stock closed at ₹109.00, recording a -2.80 (-2.50%) decline from its previous close of ₹111.80. Over the trailing 52-week trading cycle, PAR has traded between a 52-week low of ₹78.58 and a 52-week high of ₹168.25, establishing its annual trading channel. In historical performance, Par Drugs And Chemicals Limited has gained 9.9% over the past 1 year. Period returns across standard measurement intervals include: 1-week: -4.94%, 1-month: -11.19%, 6-month: +17.36%, 1-year: +9.9%, 3-year: -50.51%, 5-year: -58.52%. Daily reported trading volume reached 2,599 equity shares. On key valuation multiples as of 1 Nov 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 10.8x and a price-to-book (P/B) ratio of 1.3x, with a trailing dividend yield of 0.00%. Its market capitalization stands at ₹141.10 Cr. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.
At-a-Glance Health & Momentum Check
Company filings and balance-sheet numbers show steady day-to-day operations with stable margins and working capital.
